BlackRock’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Buy |
|
|||||
|
2025
Q1 | $21.1M | Sell |
|
|||||
|
2024
Q4 | $53.3M | Sell |
|
|||||
|
2024
Q3 | $87.1M | Buy |
|
|||||
|
2024
Q2 | $69.7M | Buy |
|
|||||
|
2024
Q1 | $55.6M | Sell |
|
|||||
|
2023
Q4 | $42.5M | Buy |
|
|||||
|
2023
Q3 | $59.3M | Buy |
|
|||||
|
2023
Q2 | $71.4M | Sell |
|
|||||
|
2023
Q1 | $82.7M | Buy |
|
|||||
|
2022
Q4 | $82.6M | Buy |
|
|||||
|
2022
Q3 | $145M | Sell |
|
|||||
|
2022
Q2 | $165M | Sell |
|
|||||
|
2022
Q1 | $211M | Sell |
|
|||||
|
2021
Q4 | $254M | Buy |
|
|||||
|
2021
Q3 | $227M | Buy |
|
|||||
|
2021
Q2 | $164M | Buy |
|
|||||
|
2021
Q1 | $115M | Buy |
|
|||||
|
2020
Q4 | $60.9M | Buy |
|